Immunocore, LLC
Biopharmaceutical company
Based in PA
AI Overview
With $200K in lobbying spend across 14 quarterly filings, Immunocore, LLC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2022 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $50K |
| 2023 | $150K |
| 2024 | $0 |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Immunocore, LLC disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Issues surrounding implementation of Infrastructure Investment and Jobs Act.
Implementation of the Infrastructure Investment and Jobs Act, Pub. L. No. 117-58, provisions related to biologic wastage rebates.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.